Prevalence of HSV-2 with different levels of vaccination.

<p>Prevalence of HSV-2 decreases as vaccine uptake increases in the total population (solid line), women ages 16–30 years (dot-dashed line), women ages over years (dashed line), women ages over years (black dotted line) and men (gray dotted line). Vaccine efficacy () levels are assumed to be (a) and (b) respectively. The proportion of females by age 12 that are HSV-1 and HSV-2 seronegative () is assumed to be .